Periyar Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.33 M
About Periyar Bio-Tech
Periyar Bio-Tech Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 June 2003 and has a history of 21 years and seven months. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Recycling & Waste Management Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.33 M.
Joicy Joseph, Babu Poulose, Meenu Babu, and One other member serve as directors at the Company.
Company Details
- Location
Ernakulam, Kerala, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100KL2003PTC016247
- Company No.
016247
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jun 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Periyar Bio-Tech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Babu Poulose  | Managing Director | 02-May-2007 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Joicy Joseph | Director | 27-Jun-2003 | Current |
| Meenu Babu | Director | 01-Jan-2019 | Current |
| Atul Paul | Director | 01-Jan-2019 | Current |
Financial Performance of Periyar Bio-Tech.
Periyar Bio-Tech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Periyar Bio-Tech?
In 2017, Periyar Bio-Tech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.33 M
₹0
Charges Breakdown by Lending Institutions
- The Federal Bank Ltd : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Nov 2015 | The Federal Bank Ltd | ₹2.33 M | Open |
How Many Employees Work at Periyar Bio-Tech?
Unlock and access historical data on people associated with Periyar Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Periyar Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Periyar Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.